135 related articles for article (PubMed ID: 11856160)
21. Bilateral cystosarcoma phyllodes of the breast: a case report of malignant form with contralateral benign form.
Mrad K; Driss M; Maalej M; Romdhane KB
Ann Diagn Pathol; 2000 Dec; 4(6):370-2. PubMed ID: 11149968
[TBL] [Abstract][Full Text] [Related]
22. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
[TBL] [Abstract][Full Text] [Related]
23. Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience.
Schwentner L; Kurzeder C; Kreienberg R; Wöckel A
Arch Gynecol Obstet; 2011 Mar; 283(3):591-6. PubMed ID: 21069366
[TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome.
Onkendi EO; Jimenez RE; Spears GM; Harmsen WS; Ballman KV; Hieken TJ
Ann Surg Oncol; 2014 Oct; 21(10):3304-9. PubMed ID: 25034817
[TBL] [Abstract][Full Text] [Related]
25. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients.
Rajan PB; Cranor ML; Rosen PP
Am J Surg Pathol; 1998 Jan; 22(1):64-9. PubMed ID: 9422317
[TBL] [Abstract][Full Text] [Related]
26. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases.
Niezabitowski A; Lackowska B; Rys J; Kruczak A; Kowalska T; Mitus J; Reinfuss M; Markiewicz D
Breast Cancer Res Treat; 2001 Jan; 65(1):77-85. PubMed ID: 11245343
[TBL] [Abstract][Full Text] [Related]
27. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
[TBL] [Abstract][Full Text] [Related]
28. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
[TBL] [Abstract][Full Text] [Related]
29. Expression of anaphase-promoting complex7 in fibroadenomas and phyllodes tumors of breast.
Kang Y; Kim JH; Lee TH; Kim TS; Jung WH; Chung HC; Park BW; Sheen SS; Han JH
Hum Pathol; 2009 Jan; 40(1):98-107. PubMed ID: 18789487
[TBL] [Abstract][Full Text] [Related]
30. Malignant cystosarcoma phyllodes.
Staren ED; Lynch G; Boyle C; Witt TR; Bines SD
Am Surg; 1994 Aug; 60(8):583-5. PubMed ID: 8030812
[TBL] [Abstract][Full Text] [Related]
31. [Breast cystosarcoma phyllodes. A clinicopathologic study of twenty-seven cases].
Wang JS; Liu HC; Su CH
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Aug; 46(2):96-103. PubMed ID: 2177371
[TBL] [Abstract][Full Text] [Related]
32. Cystosarcoma phyllodes.
Al-Jurf A; Hawk WA; Crile G
Surg Gynecol Obstet; 1978 Mar; 146(3):358-64. PubMed ID: 204070
[TBL] [Abstract][Full Text] [Related]
33. Periductal stromal tumor: a rare lesion with low-grade sarcomatous behavior.
Burga AM; Tavassoli FA
Am J Surg Pathol; 2003 Mar; 27(3):343-8. PubMed ID: 12604890
[TBL] [Abstract][Full Text] [Related]
34. Phyllodes tumor of the breast: case series of 40 patients.
Eroglu E; Irkkan C; Ozsoy M; Eroglu F
Eur J Gynaecol Oncol; 2004; 25(1):123-5. PubMed ID: 15053081
[TBL] [Abstract][Full Text] [Related]
35. Cystosarcoma phyllodes.
Schmidt B; Lantsberg L; Goldstein J; Khodadadi J
Isr J Med Sci; 1981; 17(9-10):895-8. PubMed ID: 6273359
[TBL] [Abstract][Full Text] [Related]
36. Cystosarcoma phylloides of the breast: a new therapeutic proposal.
Contarini O; Urdaneta LF; Hagan W; Stephenson SE
Am Surg; 1982 Apr; 48(4):157-66. PubMed ID: 6282155
[TBL] [Abstract][Full Text] [Related]
37. Phyllodes tumors and fibroadenoma common beginning and different ending.
Oprić S; Oprić D; Gugić D; Granić M
Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
[TBL] [Abstract][Full Text] [Related]
38. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
Kuenen-Boumeester V; Henzen-Logmans SC; Timmermans MM; van Staveren IL; van Geel A; Peeterse HJ; Bonnema J; Berns EM
J Pathol; 1999 Oct; 189(2):169-75. PubMed ID: 10547570
[TBL] [Abstract][Full Text] [Related]
39. Practical aspects in the diagnosis and management of cystosarcoma phyllodes.
Hart J; Layfield LJ; Trumbull WE; Brayton D; Barker WF; Giuliano AE
Arch Surg; 1988 Sep; 123(9):1079-83. PubMed ID: 2843145
[TBL] [Abstract][Full Text] [Related]
40. Clinical course of cystosarcoma phyllodes related to histologic appearance.
Blichert-Toft M; Hansen JP; Hansen OH; Schiodt T
Surg Gynecol Obstet; 1975 Jun; 140(6):929-32. PubMed ID: 165582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
